1700PSafe switch of treatment from the reference product to RGB-02, a proposed biosimilar pegfilgrastim: Analysis of the results of three clinical trials

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Annals of oncology 2018-10, Vol.29 (suppl_8)
Hauptverfasser:	Illes, A, Perjesi, L, Horvat-Karajz, K, Jeszenoi, N, Aradi, I, Singh, N K, Mair, S J, Kahan, Z
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page
container_issue	suppl_8
container_start_page
container_title	Annals of oncology
container_volume	29
creator	Illes, A Perjesi, L Horvat-Karajz, K Jeszenoi, N Aradi, I Singh, N K Mair, S J Kahan, Z
description
doi_str_mv	10.1093/annonc/mdy300.017
format	Article
fullrecord	<record><control><sourceid>oup</sourceid><recordid>TN_cdi_oup_primary_10_1093_annonc_mdy300_017</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/annonc/mdy300.017</oup_id><sourcerecordid>10.1093/annonc/mdy300.017</sourcerecordid><originalsourceid>FETCH-oup_primary_10_1093_annonc_mdy300_0173</originalsourceid><addsrcrecordid>eNqVj0tOwzAYhC0EEuFxAHb_AZr2d9I2hB0gHksE7C3j_G6N_IhsRyhH4bakjwuwGs1oNKOPsRuOc45tvZDeB68WrhtrxDny5oQVfLVuy1tc8lNWYFvVZbOql-fsIqVvRFy3VVuwX94gvn1ITZB-TFZbCBpyJJkd-Qw6Bgd5SxBJUySvCPoYukFlyAHeXx5KrGYgd2EfEnXwZUIyzlgZoaeNNnYTZcrG3cG9l3ZMJu0P9otpsPloIxEoa7xR0k73Rtp0xc70JHR91Es2e376fHwtw9CLPhon4yg4ih2-OOCLA76Y8Ot_1v8AmKRnDQ</addsrcrecordid><sourcetype>Publisher</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>1700PSafe switch of treatment from the reference product to RGB-02, a proposed biosimilar pegfilgrastim: Analysis of the results of three clinical trials</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Illes, A ; Perjesi, L ; Horvat-Karajz, K ; Jeszenoi, N ; Aradi, I ; Singh, N K ; Mair, S J ; Kahan, Z</creator><creatorcontrib>Illes, A ; Perjesi, L ; Horvat-Karajz, K ; Jeszenoi, N ; Aradi, I ; Singh, N K ; Mair, S J ; Kahan, Z</creatorcontrib><identifier>ISSN: 0923-7534</identifier><identifier>EISSN: 1569-8041</identifier><identifier>DOI: 10.1093/annonc/mdy300.017</identifier><language>eng</language><publisher>Oxford University Press</publisher><ispartof>Annals of oncology, 2018-10, Vol.29 (suppl_8)</ispartof><rights>The Author(s) 2018. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oup.com. 2018</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids></links><search><creatorcontrib>Illes, A</creatorcontrib><creatorcontrib>Perjesi, L</creatorcontrib><creatorcontrib>Horvat-Karajz, K</creatorcontrib><creatorcontrib>Jeszenoi, N</creatorcontrib><creatorcontrib>Aradi, I</creatorcontrib><creatorcontrib>Singh, N K</creatorcontrib><creatorcontrib>Mair, S J</creatorcontrib><creatorcontrib>Kahan, Z</creatorcontrib><title>1700PSafe switch of treatment from the reference product to RGB-02, a proposed biosimilar pegfilgrastim: Analysis of the results of three clinical trials</title><title>Annals of oncology</title><issn>0923-7534</issn><issn>1569-8041</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid/><recordid>eNqVj0tOwzAYhC0EEuFxAHb_AZr2d9I2hB0gHksE7C3j_G6N_IhsRyhH4bakjwuwGs1oNKOPsRuOc45tvZDeB68WrhtrxDny5oQVfLVuy1tc8lNWYFvVZbOql-fsIqVvRFy3VVuwX94gvn1ITZB-TFZbCBpyJJkd-Qw6Bgd5SxBJUySvCPoYukFlyAHeXx5KrGYgd2EfEnXwZUIyzlgZoaeNNnYTZcrG3cG9l3ZMJu0P9otpsPloIxEoa7xR0k73Rtp0xc70JHR91Es2e376fHwtw9CLPhon4yg4ih2-OOCLA76Y8Ot_1v8AmKRnDQ</recordid><startdate>20181001</startdate><enddate>20181001</enddate><creator>Illes, A</creator><creator>Perjesi, L</creator><creator>Horvat-Karajz, K</creator><creator>Jeszenoi, N</creator><creator>Aradi, I</creator><creator>Singh, N K</creator><creator>Mair, S J</creator><creator>Kahan, Z</creator><general>Oxford University Press</general><scope/></search><sort><creationdate>20181001</creationdate><title>1700PSafe switch of treatment from the reference product to RGB-02, a proposed biosimilar pegfilgrastim: Analysis of the results of three clinical trials</title><author>Illes, A ; Perjesi, L ; Horvat-Karajz, K ; Jeszenoi, N ; Aradi, I ; Singh, N K ; Mair, S J ; Kahan, Z</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-oup_primary_10_1093_annonc_mdy300_0173</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Illes, A</creatorcontrib><creatorcontrib>Perjesi, L</creatorcontrib><creatorcontrib>Horvat-Karajz, K</creatorcontrib><creatorcontrib>Jeszenoi, N</creatorcontrib><creatorcontrib>Aradi, I</creatorcontrib><creatorcontrib>Singh, N K</creatorcontrib><creatorcontrib>Mair, S J</creatorcontrib><creatorcontrib>Kahan, Z</creatorcontrib><jtitle>Annals of oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Illes, A</au><au>Perjesi, L</au><au>Horvat-Karajz, K</au><au>Jeszenoi, N</au><au>Aradi, I</au><au>Singh, N K</au><au>Mair, S J</au><au>Kahan, Z</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>1700PSafe switch of treatment from the reference product to RGB-02, a proposed biosimilar pegfilgrastim: Analysis of the results of three clinical trials</atitle><jtitle>Annals of oncology</jtitle><date>2018-10-01</date><risdate>2018</risdate><volume>29</volume><issue>suppl_8</issue><issn>0923-7534</issn><eissn>1569-8041</eissn><pub>Oxford University Press</pub><doi>10.1093/annonc/mdy300.017</doi></addata></record>
fulltext	fulltext
identifier	ISSN: 0923-7534
ispartof	Annals of oncology, 2018-10, Vol.29 (suppl_8)
issn	0923-7534 1569-8041
language	eng
recordid	cdi_oup_primary_10_1093_annonc_mdy300_017
source	Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection
title	1700PSafe switch of treatment from the reference product to RGB-02, a proposed biosimilar pegfilgrastim: Analysis of the results of three clinical trials
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T09%3A15%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-oup&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=1700PSafe%20switch%20of%20treatment%20from%20the%20reference%20product%20to%20RGB-02,%20a%20proposed%20biosimilar%20pegfilgrastim:%20Analysis%20of%20the%20results%20of%20three%20clinical%20trials&rft.jtitle=Annals%20of%20oncology&rft.au=Illes,%20A&rft.date=2018-10-01&rft.volume=29&rft.issue=suppl_8&rft.issn=0923-7534&rft.eissn=1569-8041&rft_id=info:doi/10.1093/annonc/mdy300.017&rft_dat=%3Coup%3E10.1093/annonc/mdy300.017%3C/oup%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_oup_id=10.1093/annonc/mdy300.017&rfr_iscdi=true